1 |
Yosioka, I., Sugawara, T., Imai, K. and Kitagawa, I. (1972) Soil bacterial hydrolysis leading to genuine aglycone. V. On ginsenosides , and Rc of the ginseng root saponins. Chem. Pharm. Bull. 20: 2418-2421.
DOI
|
2 |
Zhou, W., Feng, M. Q., Li, J. Y. and Zhou, P. (2006) Crystal structure and bioactivity of ginsenoside compound K. J. Asian Nat. Prod. Res. 8: 519-527.
DOI
|
3 |
Zhang, Z., Du, G. J., Wang, C. Z., Wen, X. D., Calway, T. and Li, Z. (2013) Compound K, a ginsenoside metabolite, inhibits colon cancer growth via multiple pathways including p53-p21 interactions. Int. J. Mol. Sci. 14: 2980-2995.
DOI
|
4 |
Joh, E. H., Lee, I. A., Jung, I. H. and Kim, D. H. (2011) Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation-the key step of inflammation. Biochem. Pharmacol. 82: 278-286.
DOI
|
5 |
Chen, J., Wu, H., Wang, Q., Chang, Y., Liu, K, Song, S., Yuan, P., Fu, J., Sun, W., Huang, Q., Liu, L., Wu, Y., Zhang, Y., Zhou, A. and Wei, W. (2014) Ginsenoside metabolite compound K alleviates adjuvant-induced arthritis by suppressing T cell activation. Inflammation 37: 1608-1615.
DOI
|
6 |
Kim, S., Kang, B. Y., Cho, S. Y., Sung, D. S., Chang, H. K., Yeom, M. H. et al. (2004) Compound K induces expression of hyaluronan synthase 2 gene in transformed human keratinocytes and increases hyaluronan in hairless mouse skin. Biochem. Piophys. Res. Commun. 316: 348-355.
DOI
|
7 |
Shin, Y. W. and Kim, D. H. (2005) Ginsenoside Rb1 and compound K in scratching behavior mouse models. J. Pharmacol. Sci. 99: 83-88.
DOI
|
8 |
Kim, K., Park, M., Lee, Y. M., Rhyu, M. R. and Kim, K. Y. (2014) Ginsenoside metabolite compound K stimulates glucagon-like peptide-1 secretion in HCI-H716 cells via bile acide receptor acivation. Arch. Pharm. Res. 37: 1193-1200.
DOI
|
9 |
Lee, H. U., Bae, E. A., Han, M. J., Kim, N. J. and Kim, D. H. (2005) Hepatoprotective effect of ginsenoside Rb1 and compound K on tert-butyl hydroperoxide-induced liver injury. Liver Int. 25: 1069-1073.
DOI
|
10 |
Yang, X.-D., Yang, Y.-Y., Ouyang, D.-S. and Yang, G.-P. (2015) A review of biotransformation and pharmacology of ginsenoside compound K. Fitoterapia 100: 208-220.
DOI
|
11 |
Zhou, W., Luo Z. and Zhou, P. (2005) Determination of ginsenoside compound- K by reversed- phase high performance liquid chromatography. Chinese journal of chromatography. 23: 270-272.
|
12 |
Jeoung, M. K., Chung, Y. B., Lee, P. S., Kim, C. S., Kim, N. H., Son, D. J., Hong, J. T. and Moon, D.-C. (2005) Determination of a ginseng saponin metabolite, IH901, in rat plasma by liquid chromatography- tandem mass spectrometry. J. Liquid Chrom. Related Tech. 28: 3205-3216.
DOI
|
13 |
Lee, P. S., Song, T. W., Sung, J.-H., Moon D.-C., Song, S. and Chung, Y. B. (2006) Pharmacokinetic characteristics and hepatic distribution of IH-901, a novel intetinal metabolite of ginseng saponin, in rats. Plant Med. 72: 204-210.
DOI
|
14 |
Paek, B., Moon, Y., Kim, J., Jia, H. Y., Kim, S. A. Sohn, D. H., Kim, J. B. and Lee, H. S. (2006) Pharmacokinetics of a ginseng saponin metabolite compound K in rats. Biopharm. Drug Dispos. 27: 39-45.
DOI
|
15 |
Poulev, A., Deus-Neumann, B. and Zenk, M. H. (1993) Immunoassays for the quantitative determination of colchicine. Planta Med. 60: 77-83.
|
16 |
Akao, T., Kanaoka, M. and Kobashi, K. (1998) Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administrationmeasurement of compound K by enzyme immunoassay. Biol. Pharm. Bull. 21: 245-249.
DOI
|